SyncAV PMTHot Line 10Devices & Arrhythmias
Dynamic Atrioventricular Optimisation in Cardiac Resynchronisation Therapy
Clinical benefit of dynamic atrioventricular optimisation during cardiac resynchronisation therapy
Presenting authorNiraj VarmaElectrophysiology · Boston UniversityNiraj Varma, MD, PhD, FRCP is a staff physician in the Section of Electrophysiology and Pacing in the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute at Cleveland Clinic. He specializes in the treatment of heart arrhythmias, with special interests in ablation for atrial fibrillation and ventricular tachycardia, defibrillator implantation, and biventricular pacing. He previously held electrophysiology positions at Loyola University Medical Center, University Hospitals of Cleveland, and Boston University Medical Center.
Overview
Pending results preclude changes to CRT programming; leaves open whether dynamic AV optimisation improves outcomes.
Key result
Dynamic atrioventricular optimisation during cardiac resynchronisation therapy has pending results regarding its clinical benefit from the ESC Congress 2026.
Discussion
Expert reaction lands here the moment SyncAV PMT reports.
Key Points
- Clinical investigation focuses on the therapeutic impact of dynamic atrioventricular optimisation during cardiac resynchronisation therapy.
- Trial evaluation tracks functional clinical benefits and electrophysiological response during cardiac resynchronisation therapy protocols.
- Late-breaking trial presentation highlights device pacing optimisation; definitive clinical findings and full trial results remain pending.
Main Result
Absolute Event Rate: 0% vs 0%